Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease

NCT07741045 is registered in ClinicalTrials.gov with Hangzhou PhecdaMed Co., Ltd. as lead sponsor.

NCT NCT07741045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07741045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease
Lead sponsor
Hangzhou PhecdaMed Co., Ltd.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
August 3, 2026
Completion date
November 15, 2028
Enrollment
300 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease 6, early-onset, parkinson's disease (pd)